Factors Influencing Comparative Bioavailability of Spironolactone Tablets
- 1 October 1977
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 66 (10), 1429-1432
- https://doi.org/10.1002/jps.2600661020
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effect of particle size on the bioavailability of digoxinEuropean Journal of Clinical Pharmacology, 1975
- Comparison of Spironolactone Tablet Dosage Forms in Healthy HumansJournal of Pharmaceutical Sciences, 1974
- Biopharmaceutics and Relevant PharmacokineticsDrug Information Bulletin, 1970
- Griseofulvin Absorption in Man After Single and Repeated Treatments and Its Correlation with Dissolution RatesJournal of Pharmaceutical Sciences, 1968
- A comparison of the use of Aldactone and Aldactone A in the treatment of hepatic ascitesGut, 1963
- AVAILABILITY OF SPIRONOLACTONE GIVEN BY MOUTHThe Lancet, 1962
- THE ALDOSTERONE BLOCKING EFFECTS OF SPIROLACTONESThe Japanese Journal of Pharmacology, 1962
- EFFECT OF A DETERGENT ON GASTROINTESTINAL ABSORPTION OF A STEROIDThe Lancet, 1961
- BLOCKING THE RENAL ELECTROLYTE EFFECTS OF MINERALOCORTICOIDS WITH AN ORALLY ACTIVE STEROIDAL SPIROLACTONEEndocrinology, 1960
- Action of New Steroids in Blocking Effects of Aldosterone and Deoxycorticosterone on SaltScience, 1957